| October 2025 | ||||||
| S | M | T | W | T | F | S |
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 | |
| Teleclass | LIFECYCLE OF MOLECULAR MICROBIOLOGY DIAGNOSTIC TECHNOLOGY: COST VERSUS CLINICAL BENEFIT BEFORE BECOMING OBSOLETE |
| Outline: | Objectives: - Understand that all technology undergoes cycles of innovation - Describe evolution of testing from early conventional microbiology tests, through to emergence of high throughput molecular arrays that can target multiple microbial pathogens in single runs - Discuss how novel promising tests can become routinely and widely used, before being superseded by faster or more precise assays; how turnaround time is of critical importance; how choice of test platform now can dictate investment flexibility in the future; and how costs can be deceptive |
| Date | April 14, 2022 |
| Live broadcast time | |
| Faculty: | Professor Colum Dunne, School of Medicine, University of Limerick, Ireland |
| Notes: | |
| Payment: | $40 |
| October 2025 | ||||||
| S | M | T | W | T | F | S |
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 | |
